Delivery Order SPE2DB24D2216-SPE2DB25FGNQD
- Not listed
- The Defense Logistics Agency awarded a $11,557.43 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $6,578.04. This competitively awarded, firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $31,145.42 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Humulin R 500 Unit/mL KwikPen insulin pens (3mL). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $16,490.54 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Humulin R 500 unit/mL KwikPen insulin in 3 mL configurations. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $25,734.37 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with completion scheduled for September 4, 2025. This contract utilizes a firm fixed price structure and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $10,014.11 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of June 2, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,503.23 for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,545.60 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with an ultimate completion date of August 7, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction to support federal medical procurement needs. The award was issued on August 6, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNQDDelivery Order
The Defense Logistics Agency awarded a $33,862.68 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price contract with an ultimate completion date of May 13, 2025, and represents a non-competitive, non-set-aside award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion blanket purchase agreement extending through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare systems globally and enables the company to deliver a broad range of medications, vaccines, and medical supplies across multiple therapeutic categories. AmerisourceBergen's federal contract portfolio demonstrates its capability as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare customers, with consistent awards covering both specialty and generic pharmaceutical products essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.9k | 5/12/25 |